AdvisorShares Pure US Cannabis ETF (MSOS) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAdvisorShares Pure US Cannabis ETF (MSOS) trades at $4.47. AdvisorShares Pure US Cannabis ETF (MSOS) is an actively managed ETF focusing on U.S. cannabis companies, providing easy access to this growing market. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for MSOS: MSOS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
AdvisorShares Pure US Cannabis ETF (MSOS) Financial Services Profile
AdvisorShares Pure US Cannabis ETF (MSOS) offers investors exposure to U.S. cannabis companies, including multi-state operators, through a U.S.-listed, actively managed ETF. Trading on the NYSE Arca, MSOS provides a convenient way to access the U.S. cannabis market, which can be difficult to navigate directly.
What Is the Investment Thesis for MSOS?
MSOS presents an investment opportunity in the expanding U.S. cannabis market, driven by increasing state-level legalization and growing consumer acceptance. With a beta of -0.14, MSOS exhibits low correlation to the broader market. The ETF's active management allows it to adapt to regulatory changes and capitalize on emerging opportunities within the sector. Key value drivers include the continued expansion of legal cannabis markets in the U.S. and potential federal policy reforms. However, investors should be aware of the risks associated with the cannabis industry, including regulatory uncertainty and market volatility. The ETF's performance is directly tied to the performance of U.S. cannabis companies, making it sensitive to changes in market sentiment and regulatory developments.
Based on FMP financials and quantitative analysis
MSOS Key Highlights
MSOS is the first U.S.-listed ETF to focus exclusively on U.S. cannabis companies, providing a unique investment vehicle.
- The ETF is actively managed, allowing for strategic allocation across a diverse range of cannabis-related businesses.
- MSOS trades on the NYSE Arca exchange, offering easy access to U.S. cannabis exposure through a single trade.
- The ETF's assets are held by BNY Mellon, a major U.S. custodial bank, ensuring security and regulatory compliance.
- MSOS has a market cap of $0.77 billion, reflecting significant investor interest in U.S. cannabis opportunities.
Who Are MSOS's Competitors?
MSOS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AVLC Avantis U.S. Large Cap Equity ETF | $91.46 | -0.88% | $1.37B | — |
| BBEM JPMorgan BetaBuilders Emerging Markets Equity ETF | $77.04 | -1.23% | $850M | — |
| ECH iShares MSCI Chile ETF | $37.43 | -2.30% | $969M | — |
| GWX State Street SPDR S&P International Small Cap ETF | $45.82 | +0.20% | $919M | — |
| IVES Dan Ives Wedbush AI Revolution ETF | $42.39 | +0.88% | $1.01B | — |
| BLK BlackRock, Inc. | $1069.63 | -0.91% | $166B | 52 5-pillar |
| BX Blackstone Inc. | $111.82 | -1.36% | $135B | 69 5-pillar |
| APOS Apollo Global Management, Inc. | $25.50 | -0.39% | $74.6B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MSOS's Key Strengths?
First U.S.-listed ETF focused exclusively on U.S. cannabis companies.
- Actively managed portfolio with experienced portfolio managers.
- Easy access to the U.S. cannabis market through a single ETF.
- Assets held by a major U.S. custodial bank (BNY Mellon).
What Are MSOS's Weaknesses?
Concentrated exposure to the U.S. cannabis industry, which is subject to regulatory uncertainty.
- Performance is highly dependent on the performance of U.S. cannabis companies.
- Expense ratio may be higher than passively managed ETFs.
- Beta of -0.14 may not appeal to all investors.
What Are the Key Risks for MSOS?
Regulatory uncertainty and potential changes in cannabis laws.
- Increased competition from other ETFs and investment vehicles.
- Market volatility and fluctuations in cannabis company valuations.
- Negative public perception of the cannabis industry.
- Changes in consumer preferences and demand for cannabis products.
What Are MSOS's Competitive Advantages?
- First-mover advantage as the first U.S.-listed ETF focused exclusively on U.S. cannabis companies.
- Active management allows for strategic allocation and adaptation to market changes.
- Easy access to the U.S. cannabis market through a single, liquid ETF.
- Reputation and expertise of the portfolio manager in the cannabis industry.
What Does MSOS Do?
AdvisorShares Pure US Cannabis ETF (MSOS) is the first actively managed U.S.-listed exchange-traded fund dedicated to investing exclusively in U.S. cannabis companies. Launched to provide investors with easy access to the burgeoning U.S. cannabis market, MSOS focuses on multi-state operators and other businesses operating within the cannabis ecosystem. The ETF trades on the NYSE Arca exchange, offering a single point of access to a diverse portfolio of cannabis securities. Before MSOS, investors seeking exposure to U.S. cannabis companies often had to navigate smaller, foreign exchanges, making the process more complex and potentially riskier. MSOS simplifies this process by consolidating multiple cannabis-related investments into a single, actively managed fund. The portfolio manager utilizes their expertise in capital markets and regulated industries to allocate assets across the investable universe of U.S. cannabis companies. MSOS's assets are held by BNY Mellon, a major U.S. custodial bank, providing an additional layer of security and trust for investors. The ETF's active management strategy allows for dynamic adjustments to the portfolio based on market conditions and regulatory developments within the rapidly evolving cannabis industry.
What Products and Services Does MSOS Offer?
- Invests in a diversified portfolio of U.S. cannabis companies.
- Provides investors with easy access to the U.S. cannabis market through a single ETF.
- Actively manages the portfolio to adapt to market conditions and regulatory changes.
- Trades on the NYSE Arca exchange, offering liquidity and transparency.
- Focuses exclusively on U.S. companies, including multi-state operators.
- Offers exposure to a variety of cannabis-related businesses, including cultivation, processing, and retail.
- Utilizes the expertise of experienced portfolio managers with a deep understanding of the cannabis industry.
How Does MSOS Make Money?
- MSOS generates revenue through management fees charged to investors.
- The ETF's performance is directly tied to the performance of its underlying holdings.
- Active management aims to outperform a passive benchmark by strategically allocating assets.
- The ETF's expense ratio covers the costs of managing the portfolio and operating the fund.
What Industry Does MSOS Operate In?
MSOS operates within the asset management industry, specifically focusing on the cannabis sector. The U.S. cannabis market is experiencing rapid growth, driven by increasing legalization and consumer demand. However, the industry faces regulatory challenges and market volatility. MSOS provides a way for investors to participate in this growth while mitigating some of the risks associated with individual stock picking. The competitive landscape includes other ETFs and investment vehicles that offer exposure to the cannabis industry, but MSOS differentiates itself by focusing exclusively on U.S. companies and employing an active management strategy.
Who Are MSOS's Key Customers?
- Retail investors seeking exposure to the U.S. cannabis market.
- Institutional investors looking for a convenient and regulated way to invest in the sector.
- Financial advisors seeking to diversify client portfolios with cannabis-related assets.
- High-net-worth individuals interested in participating in the growth of the cannabis industry.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 43 snapshots
| 2026-08-23 | 44 |
| 2026-08-31 | 44 |
| 2026-09-08 | 44 |
| 2026-09-16 | 44 |
| 2026-09-24 | 44 |
| 2026-10-04 | 44 |
| 2026-10-06 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved -12.9%.
MSOS Financials
Bull Case vs Bear Case
Bull Case
- First U.S.-listed ETF focused exclusively on U.S. cannabis companies.
- Actively managed portfolio with experienced portfolio managers.
- Easy access to the U.S. cannabis market through a single ETF.
- Assets held by a major U.S. custodial bank (BNY Mellon).
Bear Case
- Concentrated exposure to the U.S. cannabis industry, which is subject to regulatory uncertainty.
- Performance is highly dependent on the performance of U.S. cannabis companies.
- Expense ratio may be higher than passively managed ETFs.
- Beta of -0.14 may not appeal to all investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MSOS Latest News
-
AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) Shares Gap Down – Here’s What Happened
defenseworld.net · Oct 2, 2026
-
MSOS: Pause On Cannabis Rescheduling - And Why Trulieve Is A Sneaky Pick
seekingalpha.com · Oct 1, 2026
-
Cannabis Investors Were Betting On Washington, Then Washington Hit Pause
Yahoo! Finance: MSOS News · Sep 30, 2026
-
Trulieve Sinks 14% as DEA Judge Pauses Cannabis Rescheduling Over GAO Report Flagging “Gaps”
Yahoo! Finance: MSOS News · Sep 30, 2026
MSOS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MSOS.
Price Targets
Wall Street price target analysis for MSOS.
MSOS MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MSOS; grades run from A+ (80-100) to F (below 30).
Latest News
AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) Shares Gap Down – Here’s What Happened
MSOS: Pause On Cannabis Rescheduling - And Why Trulieve Is A Sneaky Pick
Cannabis Investors Were Betting On Washington, Then Washington Hit Pause
Trulieve Sinks 14% as DEA Judge Pauses Cannabis Rescheduling Over GAO Report Flagging “Gaps”
MSOS Financials Stock FAQ
What do analysts say about MSOS stock?
Analyst coverage of MSOS is still developing, reflecting the evolving nature of the cannabis industry. Generally, analysts recognize the growth potential of the U.S. cannabis market and the role that MSOS plays in providing access to this market. Key valuation metrics to consider include the ETF's net asset value (NAV) and its expense ratio.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The cannabis industry is subject to rapid regulatory changes, which could impact the performance of MSOS.
- Past performance is not indicative of future results.
- Investors should consult with a financial advisor before making investment decisions.